Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/13695
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKundu, Mrityunjoy-
dc.contributor.authorSingh, Jagadish-
dc.contributor.authorSingh, Brijesh-
dc.contributor.authorGhosh, Tirtha-
dc.contributor.authorMaiti, B C-
dc.contributor.authorMaity, T K-
dc.date.accessioned2012-03-09T12:55:52Z-
dc.date.available2012-03-09T12:55:52Z-
dc.date.issued2012-03-
dc.identifier.urihttp://hdl.handle.net/123456789/13695-
dc.description493-497en_US
dc.description.abstract3,5-Diaryl-1,2,4-oxadiazole derivatives are synthesized by condensation reaction of amidoximes with aromatic acid chloride. Amidoximes are obtained from aromatic nitriles and acid chlorides from corresponding aromatic monocarboxylic acid derivatives. There are broad possibilities of preparing several such compounds in this series by using different aromatic nitriles as well as different aromatic monocarboxylic acid derivatives. The synthesized compounds are evaluated for their anticancer activity by using mice specific Ehrlich Ascites Carcinoma cell (EAC cells) in Swiss albino mice model. Synthesized compounds (dose 25 mg/kg body weight) show significant reduction of tumor cell count as well as tumor weight. Life span of the treated mice also increases. The standard drug used for the study is 5-fluorouracil (5 mg/kg body weight).en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJC-B Vol.51B(03) [March 2012]en_US
dc.subjectAmidoximeen_US
dc.subject1,2,4-Oxadiazoleen_US
dc.subjectAcid Chlorideen_US
dc.subjectEAC Cellsen_US
dc.titleSynthesis and anticancer activity of 3,5-diaryl-1,2,4-oxadiazole derivativesen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.51B(03) [March 2012]

Files in This Item:
File Description SizeFormat 
IJCB 51B(3) 493-497.pdf64.79 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.